BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18076073)

  • 1. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
    Pocza P; Süli-Vargha H; Darvas Z; Falus A
    Int J Cancer; 2008 May; 122(9):1972-80. PubMed ID: 18076073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein.
    Ntayi C; Labrousse AL; Debret R; Birembaut P; Bellon G; Antonicelli F; Hornebeck W; Bernard P
    J Invest Dermatol; 2004 Feb; 122(2):256-65. PubMed ID: 15009703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA.
    Toupance S; Brassart B; Rabenoelina F; Ghoneim C; Vallar L; Polette M; Debelle L; Birembaut P
    Clin Exp Metastasis; 2012 Jun; 29(5):511-22. PubMed ID: 22434583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elastin-derived peptides: matrikines critical for glioblastoma cell aggressiveness in a 3-D system.
    Coquerel B; Poyer F; Torossian F; Dulong V; Bellon G; Dubus I; Reber A; Vannier JP
    Glia; 2009 Dec; 57(16):1716-26. PubMed ID: 19373935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells.
    Cheung KJ; Li G
    Int J Oncol; 2002 Dec; 21(6):1361-5. PubMed ID: 12429989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
    Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elastin connection and melanoma progression.
    Hornebeck W; Robinet A; Duca L; Antonicelli F; Wallach J; Bellon G
    Anticancer Res; 2005; 25(4):2617-25. PubMed ID: 16080502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A.
    Desch A; Strozyk EA; Bauer AT; Huck V; Niemeyer V; Wieland T; Schneider SW
    Am J Pathol; 2012 Aug; 181(2):693-705. PubMed ID: 22659470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes.
    Senior RM; Griffin GL; Mecham RP; Wrenn DS; Prasad KU; Urry DW
    J Cell Biol; 1984 Sep; 99(3):870-4. PubMed ID: 6547961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Becker JC; Ruiter DJ; van Muijen GN
    J Invest Dermatol; 2000 Oct; 115(4):625-32. PubMed ID: 10998134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
    Goydos JS; Gorski DH
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
    Saladi SV; Keenen B; Marathe HG; Qi H; Chin KV; de la Serna IL
    Mol Cancer; 2010 Oct; 9():280. PubMed ID: 20969766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of galectin-3 expression with melanoma progression and prognosis.
    Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
    Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
    Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
    Woodward JK; Rennie IG; Burn JL; Sisley K
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility?
    Mitchell B; Leone D; Feller K; Menon S; Bondzie P; Yang S; Park HY; Mahalingam M
    Hum Pathol; 2014 Oct; 45(10):2094-100. PubMed ID: 25130395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.